Allspring Global Investments’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.02M Sell
10,106
-2,618
-21% -$860K 0.01% 973
2025
Q4
$4.51M Sell
12,724
-7,642
-38% -$2.58M 0.01% 876
2025
Q3
$6.78M Sell
20,366
-1,935
-9% -$602K 0.01% 810
2025
Q2
$8.83M Sell
22,301
-12,958
-37% -$5.21M 0.01% 757
2025
Q1
$15.3M Sell
35,259
-21,881
-38% -$8.78M 0.03% 601
2024
Q4
$20.9M Buy
57,140
+5,726
+11% +$2.4M 0.03% 524
2024
Q3
$26.7M Sell
51,414
-2,255
-4% -$1.2M 0.04% 488
2024
Q2
$29.1M Sell
53,669
-32,039
-37% -$16.9M 0.05% 455
2024
Q1
$44.4M Buy
85,708
+2,926
+4% +$1.46M 0.07% 357
2023
Q4
$39M Sell
82,782
-3,859
-4% -$1.78M 0.06% 384
2023
Q3
$37.7M Sell
86,641
-18,956
-18% -$8.6M 0.07% 374
2023
Q2
$46.9M Sell
105,597
-54,455
-34% -$25.1M 0.08% 342
2023
Q1
$73.6M Sell
160,052
-10,056
-6% -$4.79M 0.12% 217
2022
Q4
$87.3M Buy
170,108
+47,420
+39% +$24.1M 0.15% 175
2022
Q3
$55.7M Sell
122,688
-531
-0.4% -$254K 0.1% 258
2022
Q2
$59.5M Sell
123,219
-38,366
-24% -$19M 0.1% 269
2022
Q1
$79.4M Buy
161,585
+3,053
+2% +$1.4M 0.1% 270
2021
Q4
$73.5M Buy
+158,532
New +$66.7M 0.08% 315

Other funds holding ELV

Allspring Global Investments's ELV Position: Q1 2026 in Review

Allspring Global Investments reduced its Elevance Health (ELV) stake by 21% in Q1 2026, selling an estimated $860K and leaving 10,106 shares worth $3.02M. The position accounts for 0.01% of the portfolio, ranked #973.

Allspring Global Investments first reported a position in ELV in Q4 2021 and has held it in 18 quarters since. The position peaked at $87.3M in Q4 2022. 1,467 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Allspring Global Investments held 10,106 shares of Elevance Health worth $3.02M as of Q1 2026.
  • Allspring Global Investments sold 2,618 Elevance Health shares in Q1 2026, an estimated $860K.
  • Elevance Health made up 0.01% of Allspring Global Investments's portfolio in Q1 2026, its #973 holding.
  • Allspring Global Investments first reported a position in Elevance Health in Q4 2021 and has held it in 18 quarters since.
  • Allspring Global Investments's Elevance Health position peaked at $87.3M in Q4 2022.
  • 1,467 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Allspring Global Investments's 13F filing for Q1 2026, filed 5 May 2026.